A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models

C. Hindley, A. Biondo, J. Brothwood, K.H. Dao, N. Kandola, J. Lyons, Y. Nakatsuru, T. Smyth, S. Wagner, N. Wallis, K. Hearn

European Journal of Cancer(2022)

引用 0|浏览1
暂无评分
关键词
inhibitors,colorectal cancer,shp2,vertical inhibition approach,kras-mutant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要